San Francisco, California-- (Newsfile Corp. - January 30, 2025) - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

Ageing patient populations and technological advancements are emerging as key drivers of healthcare innovation and delivery.

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize AMD at first.

The "Fluorescein Angiography Market by Type, by Application, by End-User, and By Region" report has been added to ...

A new study has revealed that managing eye conditions through enhanced optometric services at local optometrists, rather than relying solely on hospital eye services (HES), can significantly reduce ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

OCTA outperformed OCT alone or with OCTA in glaucoma detection based on accuracy, sensitivity, specificity and AUC. Integrating OCTA with deep learning may contribute to more effective glaucoma ...

Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...